Navigation Links
NanoPowers Raises CHF 5 Million ($4.5 Million) in Series A Financing to Support Development of Breakthrough Urinary Incontinence Device
Date:6/1/2010

LAUSANNE, Switzerland, June 1, 2010 /PRNewswire/ -- NanoPowers SA, a medical device company that leverages its unique artificial muscle technology to restore or improve muscle function, today announced the closing of a CHF 5 million ($4.5 million) series A financing. The financing round was led by Novartis Venture Funds (NVF). Also participating in the financing were Initiative Capital Romandie (ICR) and Gran Plasa SA. Novartis Venture Funds were also seed investors in the company.

Martin Horst, PhD, chief executive officer, said: "We are very pleased with the ongoing support of the Novartis Venture Funds, and welcome ICR and Gran Plasa to our investor base. We will use the proceeds from the financing to finalize the development of our lead product ARTUS, a breakthrough artificial urinary sphincter, and initiate the first clinical studies. ARTUS addresses a huge unmet medical need, and is the first device of its kind that also lends itself to be easily implanted in women, who are by far the most affected by severe incontinences. Incontinence constitutes a devastating disability, affecting self-confidence and self image, and often leads to social isolation."

Florent Gros, Managing Director of the Novartis Venture Funds, said: "We are excited to support NanoPowers' development of their breakthrough technology applied to artificial sphincters. Incontinence is one of the largest untapped markets in the medical device industry, while demographic changes in western countries are significantly increasing the incidence of incontinences. We believe that ARTUS has the potential to significantly improve patients' quality of live, while substantially reducing treatment c
'/>"/>

SOURCE NanoPowers SA
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Curexo Technology Corporation Raises $13.2 Million
2. Cardinal Health Raises Quarterly Dividend By 11 Percent
3. IMPLANET Raises Additional EUR 8 Million (USD 11 Million) to Fuel Deployment
4. Intercept Pharmaceuticals Raises $25 Million Series B Financing
5. The Oclaro Next-Generation Orion Fiber-Coupled Diode Laser Raises the Bar for Performance, Cost and Reliability for Solid State Lasers
6. Circassia Raises GBP15 Million ($25 Million) in Oversubscribed Investment Round
7. Apnex Medical, Inc. Raises Additional $14 Million
8. Cambridge-based Ligon Discovery Raises $1M in Seed Funding
9. FREE Drug Discount Card Saves Money on Prescriptions and Raises Funds for Americas Disabled Veterans
10. CareFusion Reports First Quarter Results, Raises Full-Year Outlook
11. NxStage(R) Reports Third Quarter 2009 Financial Results and Raises Revenue Guidance for Fiscal 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... Calif. , June 19, 2013  Omnicell, ... provider of medication and supply management solutions and ... it was named the number one overall pharmacy ... & Infrastructure Report. KLAS, a leading independent healthcare ... automation equipment vendors in its annual rankings. Omnicell ...
(Date:6/19/2013)... Pharma IQ is pleased to announce ... of the results from an industry survey conducted earlier this ... that CROs would be an area of active investment in ... 6 or more clinical trials in the BRIC region. The ... USA Summit explores the latest trends, challenges ...
(Date:6/19/2013)... 19, 2013  It may seem like an odd pairing: ... cancer. But these were two of the most talked about ... Annual Meeting & Expo that just convened in ... focus by some of the top internal medicine experts in ... new research that can not only save lives, but help ...
Breaking Medicine Technology:Omnicell Named Top Vendor in 2013 KLAS Pharmacy Automation Equipment Rankings 2Omnicell Named Top Vendor in 2013 KLAS Pharmacy Automation Equipment Rankings 3Omnicell Named Top Vendor in 2013 KLAS Pharmacy Automation Equipment Rankings 4Pharma IQ Presents the Latest Trends in Clinical Trial Supply 2"Miracle" Breast Cancer Drug and "Youth Hormone" Pill Steal Show at Prestigious Endocrine Society Conference 2"Miracle" Breast Cancer Drug and "Youth Hormone" Pill Steal Show at Prestigious Endocrine Society Conference 3"Miracle" Breast Cancer Drug and "Youth Hormone" Pill Steal Show at Prestigious Endocrine Society Conference 4
... ,Automation continues to gain importance in modern ... consolidation, rising demands from clinicians for rapid ... licensed medical technologists. Ultimately, the laboratories that ... to meet these modern demands. , ,Within ...
... Content Editor Medcompare.com ,According to a November, 2005 ... HIV/AIDS) and the World Health Organization, the number of people ... million people in 2005, with over 3 million deaths caused ... Disease Control shows that over one million people in the ...
Cached Medicine Technology:Optimizing Quality Control Data Management 2Optimizing Quality Control Data Management 3Optimizing Quality Control Data Management 4Optimizing Quality Control Data Management 5Rapid HIV Testing Increases Possibility of Treatment 2Rapid HIV Testing Increases Possibility of Treatment 3
(Date:6/19/2013)... led by researchers at The University of Texas MD ... show remarkable promise for the treatment of relapsed or ... interim findings of the 18-center Phase 2 study were ... Medicine . Previous interim findings were presented in December ... Meeting and Exposition. , Unprecedented results, fewer ...
(Date:6/19/2013)... half as many emergency department visits if their primary ... more days a week, according to new research from ... Johns Hopkins University. , The new study was published ... and will be presented at the AcademyHealth Annual ... in understanding where primary care practices and medical home ...
(Date:6/19/2013)... Nearly 70 percent of Americans are on at ... take two, Mayo Clinic researchers say. Antibiotics, antidepressants ... study found. Twenty percent of patients are on ... findings, published online in the journal Mayo ... and video of Dr. Jennifer St. Sauver talking ...
(Date:6/19/2013)... 19, 2013 North Carolina-based life ... changes to advance development of its technologies. , ... support the advanced development of our product candidates ... the Company’s management structure and engaged industry leaders ... announced that Michael Galiger will serve as Vice ...
(Date:6/19/2013)... Brightree LLC , the leading provider of ... post-acute care industry, has been ranked for the first time ... 100 (HCI 100) list. This prestigious list features the ... of revenue during the last fiscal year. Since 2005, Brightree’s ... and the company has built its organization to more than ...
Breaking Medicine News(10 mins):Health News:Ibrutinib continues strong showing against mantle cell lymphoma 2Health News:Extended primary care office hours might help keep kids out of the emergency department 2Health News:Nearly 7 in 10 Americans are on prescription drugs, Mayo Clinic study finds 2Health News:Entegrion Announces Organizational Changes to Support Advanced Product Development 2Health News:Entegrion Announces Organizational Changes to Support Advanced Product Development 3Health News:Brightree Debuts on List of Top 100 Healthcare Technology Companies 2Health News:Brightree Debuts on List of Top 100 Healthcare Technology Companies 3
... Roche and Memory Pharmaceuticals (Nasdaq: MEMY ... a definitive merger agreement for Roche to acquire all ... transaction for an aggregate price of approximately USD 50 ... Memory Pharmaceuticals develops innovative drug candidates for the treatment ...
... 25 Pennsylvania will benefit a potential $16 million ... Botvin LifeSkills Training program, a drug abuse ... released by the Prevention Research Center at Pennsylvania ... of this highly effective program yields a return on ...
... DETROIT, Nov. 24 Caraco Pharmaceutical,Laboratories, Ltd. (NYSE Alternext ... response to the FDA warning letter that was received ... requested a response from Caraco,within 15 business days, ending ... As previously disclosed, the warning letter was issued ...
... , , MONDAY, Nov. 24 (HealthDay News) -- A drug ... and caused fewer side effects than the widely-used migraine ... drug maker Merck & Co. , Zolmitriptan and other ... side effects, including dizziness, tingling and numbness of the ...
... University of California, San Diego (UCSD) and the Moores ... novel drug target for an often difficult-to-treat form of ... pattern of a specific family of enzymes in patients ... of adult leukemia. , Paul Insel, M.D., professor ...
... announced on Friday that Garvan endocrinologist and PhD student, Dr ... the AAAS Science "Dance your PhD" contest. See ... Science magazine challenged researchers around the world to interpret ... share it with the world on YouTube by mid-November. ...
Cached Medicine News:Health News:Roche Signs Definitive Agreement to Acquire Memory Pharmaceuticals 2Health News:Roche Signs Definitive Agreement to Acquire Memory Pharmaceuticals 3Health News:Roche Signs Definitive Agreement to Acquire Memory Pharmaceuticals 4Health News:Drug Abuse and Violence Prevention Program Generates $16 Million in Potential Savings 2Health News:Drug Abuse and Violence Prevention Program Generates $16 Million in Potential Savings 3Health News:Caraco Pharmaceutical Laboratories, Ltd. Responds to FDA Warning Letter 2Health News:New Migraine Drug Shows Promise 2Health News:UCSD researchers identify potential new drug target for chronic leukemia 2Health News:Ph.D. student Sue Lynn Lau dances her way to Chicago 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: